Literature DB >> 16496033

Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells.

Zongjun Shao1, Lillian E Dyck, Haitao Wang, Xin-Min Li.   

Abstract

OBJECTIVE: Atypical antipsychotic drugs have been shown to protect PC12 cells from cell death induced by a variety of stimuli in culture. Recently, it has been postulated that trophic factors, such as brain-derived neurotrophic factor (BDNF), play a role in preventing cell death. It has been shown that antipsychotic drugs attenuate the decrease in rat hippocampal BDNF that results from immobilization-induced stress. We aimed to determine whether the neuroprotective effects of antipsychotic drugs could be mediated through glial cell line-derived neurotrophic factor (GDNF).
METHODS: We investigated the effects of the atypical antipsychotic drugs quetiapine and clozapine and the typical antipsychotic haloperidol on the secretion of GDNF from rat C6 glioma cells.
RESULTS: All 3 drugs increased the amount of GDNF secreted from C6 glioma cells into the medium after 48-hour culture. The intracellular content of GDNF was not altered by treatment with any of the antipsychotic drugs. None of the antipsychotic drugs decreased cell number.
CONCLUSION: This study suggests that stimulation of GDNF release from glial cells by antipsychotic drugs might underlie some of their neuroprotective properties in situ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496033      PMCID: PMC1325064     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  26 in total

1.  Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs.

Authors:  Ou Bai; Jennifer Chlan-Fourney; Rudy Bowen; David Keegan; Xin-Min Li
Journal:  J Neurosci Res       Date:  2003-01-01       Impact factor: 4.164

Review 2.  Synaptic plasticity and mood disorders.

Authors:  R S Duman
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

3.  Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients.

Authors:  M Takahashi; O Shirakawa; K Toyooka; N Kitamura; T Hashimoto; K Maeda; S Koizumi; K Wakabayashi; H Takahashi; T Someya; H Nawa
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

4.  Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration.

Authors:  F Angelucci; A A Mathé; L Aloe
Journal:  J Neurosci Res       Date:  2000-06-15       Impact factor: 4.164

5.  Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments.

Authors:  Y P Tang; Y L Ma; C C Chao; K Y Chen; E H Lee
Journal:  J Neurosci Res       Date:  1998-09-01       Impact factor: 4.164

6.  Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide.

Authors:  Zelan Wei; Ou Bai; J Steven Richardson; Darrell D Mousseau; Xin-Min Li
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

7.  The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis.

Authors:  Hong Qing; Haiyun Xu; Zelan Wei; Kurt Gibson; Xin-Min Li
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

8.  Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal.

Authors:  Ou Bai; Zelan Wei; Wenfu Lu; Rudy Bowen; David Keegan; Xin-Min Li
Journal:  J Neurosci Res       Date:  2002-07-15       Impact factor: 4.164

9.  Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration.

Authors:  Jennifer Chlan-Fourney; Paula Ashe; Kirk Nylen; Augusto V Juorio; Xin Min Li
Journal:  Brain Res       Date:  2002-11-01       Impact factor: 3.252

10.  Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) expression and localization.

Authors:  Zelan Wei; Darrell D Mousseau; J Steven Richardson; Lillian E Dyck; Xin-Min Li
Journal:  J Neurosci Res       Date:  2003-12-15       Impact factor: 4.164

View more
  11 in total

1.  Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

Authors:  Renan P Souza; Vincenzo de Luca; Gary Remington; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy; Albert H C Wong
Journal:  Psychopharmacology (Berl)       Date:  2010-04-06       Impact factor: 4.530

2.  Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.

Authors:  Xiaoming Hu; Hui Zhou; Dan Zhang; Sufen Yang; Li Qian; Hung-Ming Wu; Po-See Chen; Belinda Wilson; Hui-Ming Gao; Ru-band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-26       Impact factor: 4.147

3.  Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Authors:  Fei Ye; Qiongqiong Zhan; Wenhuan Xiao; Weiwei Sha; Xiaobin Zhang
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

4.  Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats.

Authors:  Samira S Valvassori; Laura Stertz; Ana C Andreazza; Maria I Rosa; Flávio Kapczinski; Emilio L Streck; João Quevedo
Journal:  Metab Brain Dis       Date:  2008-05-22       Impact factor: 3.584

5.  N-acetyl cysteine mitigates the acute effects of cocaine-induced toxicity in astroglia-like cells.

Authors:  Ramesh B Badisa; Sanjay S Kumar; Elizabeth Mazzio; Rasheda D Haughbrook; John R Allen; Michael W Davidson; Cheryl A Fitch-Pye; Carl B Goodman
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

6.  Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.

Authors:  Marta Jóźwiak-Bębenista; Edward Kowalczyk
Journal:  Neurochem Res       Date:  2016-11-30       Impact factor: 3.996

7.  Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.

Authors:  Xiaowei Tang; Chao Zhou; Ju Gao; Weiwei Duan; Miao Yu; Wenhuan Xiao; Xiaobin Zhang; Hui Dong; Xiang Wang; Xiangrong Zhang
Journal:  BMC Psychiatry       Date:  2019-08-16       Impact factor: 3.630

8.  Iboga Inspired N-Indolylethyl-Substituted Isoquinuclidines as a Bioactive Scaffold: Chemoenzymatic Synthesis and Characterization as GDNF Releasers and Antitrypanosoma Agents.

Authors:  Mariana Pazos; Estefania Dibello; Juan Manuel Mesa; Dalibor Sames; Marcelo Alberto Comini; Gustavo Seoane; Ignacio Carrera
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

Review 9.  GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease.

Authors:  Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo
Journal:  Front Neuroanat       Date:  2015-02-13       Impact factor: 3.856

Review 10.  The GDNF Family: A Role in Cancer?

Authors:  Graeme C Fielder; Teresa Wen-Shan Yang; Mahalakshmi Razdan; Yan Li; Jun Lu; Jo K Perry; Peter E Lobie; Dong-Xu Liu
Journal:  Neoplasia       Date:  2017-12-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.